ConductScience.org, home

Paper22945588

Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.

Sauerborn M and 6 others. J Clin Immunol, 2013. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory. Papers, record 22945588. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22945588

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibody response against Betaferon® in immune tolerant mice: involvement of marginal zone B-cells and CD4+ T-cells and apparent lack of immunological memory.
PubMed
Journal
J Clin Immunol
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2021-10-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sauerborn MMelody
2van Beers MMMiranda M C
3Jiskoot WWim
4Kijanka GMGrzegorz M
5Boon LLouis
6Schellekens HHuub
7Brinks VVera

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B-Lymphocyte SubsetsMajor topic
CD4-Positive T-LymphocytesMajor topic
Immune ToleranceMajor topic
Immunoglobulin GMajor topic
Immunologic MemoryMajor topic
Interferon-betaMajor topic
Lymphoid TissueMajor topic
Animals
Female
Interferon beta-1b
Lymphocyte Cooperation
Lymphocyte Depletion
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Models, Animal
Recombinant Proteins

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16177769T cell control of the antibody response to the T-independent antigen, DAGG-Ficoll.J Immunol1982https://conductscience.org/library/papers/6177769PubMed
218606364How to predict and prevent the immunogenicity of therapeutic proteins.Biotechnol Annu Rev2008https://conductscience.org/library/papers/18606364PubMed
320739220Molecular pathways regulating CD4(+) T cell differentiation, anergy and memory with implications for vaccines.Trends Mol Med2010https://conductscience.org/library/papers/20739220PubMed
417470546Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection.Infect Immun2007https://conductscience.org/library/papers/17470546PubMed
519269256Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics.Clin Immunol2009https://conductscience.org/library/papers/19269256PubMed
615948027Development of a transgenic mouse model immune tolerant for human interferon Beta.Pharm Res2005https://conductscience.org/library/papers/15948027PubMed
718950867Reduced notch activity is associated with an impaired marginal zone B cell development and function in Sly1 mutant mice.Mol Immunol2009https://conductscience.org/library/papers/18950867PubMed
821544687Oxidized and aggregated recombinant human interferon beta is immunogenic in human interferon beta transgenic mice.Pharm Res2011https://conductscience.org/library/papers/21544687PubMed
919963283Immunological mechanism underlying the immune response to recombinant human protein therapeutics.Trends Pharmacol Sci2010https://conductscience.org/library/papers/19963283PubMed
1020499141Aggregated recombinant human interferon Beta induces antibodies but no memory in immune-tolerant transgenic mice.Pharm Res2010https://conductscience.org/library/papers/20499141PubMed
119587963Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).Pharm Res1998https://conductscience.org/library/papers/9587963PubMed
1218482185Epoetin-associated pure red cell aplasia: past, present, and future considerations.Transfusion2008https://conductscience.org/library/papers/18482185PubMed
1311244048B cell development pathways.Annu Rev Immunol2001https://conductscience.org/library/papers/11244048PubMed
1419857496Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta.J Immunol Methods2010https://conductscience.org/library/papers/19857496PubMed
1511043775B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.Immunol Rev2000https://conductscience.org/library/papers/11043775PubMed
1611282547
Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.
Eur Cytokine Netw2001https://conductscience.org/library/papers/11282547PubMed
176984419Antibody formation in mouse bone marrow during secondary type responses to various thymus-independent antigens.Immunobiology1982https://conductscience.org/library/papers/6984419PubMed
186969777T cell regulation of IgG subclass antibody production in response to T-independent antigens.J Exp Med1981https://conductscience.org/library/papers/6969777PubMed
1910933592B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory".Immunol Rev2000https://conductscience.org/library/papers/10933592PubMed
208293465T and B memory cells.Cell1994https://conductscience.org/library/papers/8293465PubMed

See all 32 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41103353Efficacy, immunogenicity, and safety of pneumococcal conjugate vaccine in children: a systematic review and meta-analysis.Front Pediatr2025https://conductscience.org/library/papers/41103353PubMed
40466641Machine-guided dual-objective protein engineering for deimmunization and therapeutic functions.Cell Syst2025https://conductscience.org/library/papers/40466641PubMed
37150860Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities.Adv Sci (Weinh)2023https://conductscience.org/library/papers/37150860PubMed
34458822Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies.RSC Chem Biol2021https://conductscience.org/library/papers/34458822PubMed
27806057Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.PLoS One2016https://conductscience.org/library/papers/27806057PubMed
27044944Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.J Pharm Sci2016https://conductscience.org/library/papers/27044944PubMed
25630815The immunogenicity of antibody aggregates in a novel transgenic mouse model.Pharm Res2015https://conductscience.org/library/papers/25630815PubMed
25133276Recombinant murine growth hormone particles are more immunogenic with intravenous than subcutaneous administration.J Pharm Sci2014https://conductscience.org/library/papers/25133276PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22945588

GET https://conductscience.org/api/papers/v1/22945588/references?page=2